EP3790548
Aðferðir til að bæta lífaðgengi og útsetningu spennustýrðs kalíumgangaopnara
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.5.2019EP published:
23.8.2023EP application number:
19727216.4
EP translation filed:
13.11.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
9.5.2039Expiry date:
9.5.2026Next due date:
31.5.2026
Title in English:
METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENERLanguage of the patent:
English
Timeline
Today
10.5.2019EP application
23.8.2023EP Publication
13.11.2023Translation submitted
15.12.2023Registration published
9.5.2026Expires
Owner
Name:
Xenon Pharmaceuticals Inc.Address:
200-3650 Gilmore Way, Burnaby, British Columbia V5G 4W8, CA
Inventor
Name:
BEATCH, Gregory N.Address:
West Vancouver, British Columbia V7W 2H8, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862670253 PDate:
11.5.2018Country:
US
Classification
Categories:
A61K 31/472, A61P 25/08
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 18.4.2024
Expires: 9.5.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 9.5.2025
Expires: 9.5.2026
Payer: Árnason Faktor ehf.